Perrigo Reaches Year Anniversary For First OTC Brand Switch With Sixth Packaging Approval

 
• By Bob Kronemyer

Latest FDA approval for mometasone furoate, 50-mcg metered spray, is for three 144-spray containers. Nasonex 24HR Allergy is Perrigo’s first OTC switch of national brand and first mometasone furoate offered nonprescription in US.

• Source: Shutterstock

More from Rx-to-OTC Switch

More from Health